06 Apr

Canadian based Thornhill Medical Engages BioPortUSA

BioPortUSA is excited to announce that it was recently engaged by Thornhill Medical, to conduct a market landscape for their ClearMate product. Leslie Gouldie, CEO of Thornhill was interested in seeing whether the U.S. was a viable market for this novel medical device which is used to help treat people who have been exposed to Carbon Monoxide. “There is no sense in pursuing the U.S. market if the numbers just don’t add up.”

A market landscape identifies the product markets and product market segments that would include a company's invention if it were commercialized, based on current published information about product markets.  Market landscapes include information on current market size as well as rates of growth or contraction estimated by market analysts, and can be used by you to assess the potential sources and level of demand for your contemplated commercial product. It also includes a competitive analysis.

Thornhill Medical was spun off from the University Health Network, Toronto, Canada, in 2003 to commercialize the ideas and research of Drs. Joe Fisher and Ludwik Fedorko, Steve Iscoe, Jim Duffin and a group of founding engineers. Today, Thornhill Medical’s innovative medical technology is changing the global face of emergency medicine for first responders and the military. Thornhill Medical, a science based company has more than 40 patents patents awarded and pending.